6LI0 image
Deposition Date 2019-12-10
Release Date 2020-02-26
Last Version Date 2024-10-23
Entry Detail
PDB ID:
6LI0
Title:
Crystal structure of GPR52 in complex with agonist c17
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.21
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Chimera of G-protein coupled receptor 52 and Flavodoxin
Gene (Uniprot):DVU_2680, GPR52
Mutagens:A130W,Y1098W,A264L,W278Q,C314P,S318A,N321D,V323T
Chain IDs:A
Chain Length:468
Number of Molecules:1
Biological Source:Homo sapiens, Desulfovibrio vulgaris str. Hildenborough
Primary Citation
Structural basis of ligand recognition and self-activation of orphan GPR52.
Nature 579 152 157 (2020)
PMID: 32076264 DOI: 10.1038/s41586-020-2019-0

Abstact

GPR52 is a class-A orphan G-protein-coupled receptor that is highly expressed in the brain and represents a promising therapeutic target for the treatment of Huntington's disease and several psychiatric disorders1,2. Pathological malfunction of GPR52 signalling occurs primarily through the heterotrimeric Gs protein2, but it is unclear how GPR52 and Gs couple for signal transduction and whether a native ligand or other activating input is required. Here we present the high-resolution structures of human GPR52 in three states: a ligand-free state, a Gs-coupled self-activation state and a potential allosteric ligand-bound state. Together, our structures reveal that extracellular loop 2 occupies the orthosteric binding pocket and operates as a built-in agonist, conferring an intrinsically high level of basal activity to GPR523. A fully active state is achieved when Gs is coupled to GPR52 in the absence of an external agonist. The receptor also features a side pocket for ligand binding. These insights into the structure and function of GPR52 could improve our understanding of other self-activated GPCRs, enable the identification of endogenous and tool ligands, and guide drug discovery efforts that target GPR52.

Legend

Protein

Chemical

Disease

Primary Citation of related structures